Torrent Pharmaceuticals Limited
TORNTPHARM
Rang in aandelen
#1203
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Aandeelprijs
$49.87
Marktkapitalisatie
$18.97B
Verandering (1 dag)
-0.87%
Verandering (1 jaar)
22.25%
Land
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Categorie
Healthcare
Aantal uitstaande aandelen voor Torrent Pharmaceuticals Limited (TORNTPHARM)
Aantal uitstaande aandelen per June 2026: 338.45M
Volgens de laatste financiële rapporten en de aandelenkoers van Torrent Pharmaceuticals Limited bedraagt het huidige aantal uitstaande aandelen 338.45M. Aan het einde van March 2024 had het bedrijf 338.45M uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Torrent Pharmaceuticals Limited (TORNTPHARM) van 2005 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2026 (TTM) | 338.45M | 0.01% |
| 2025 | 338.41M | -0.01% |
| 2024 | 338.45M | 0.00% |
| 2023 | 338.45M | 0.00% |
| 2022 | 338.45M | 0.00% |
| 2021 | 338.45M | 0.00% |
| 2020 | 338.45M | 0.00% |
| 2019 | 338.45M | 0.00% |
| 2018 | 338.45M | 0.00% |
| 2017 | 338.45M | 0.00% |
| 2016 | 338.45M | 0.00% |
| 2015 | 338.45M | 0.00% |
| 2014 | 338.45M | 0.00% |
| 2013 | 338.45M | 0.00% |
| 2012 | 338.45M | 0.00% |
| 2011 | 338.44M | 0.00% |
| 2010 | 338.44M | 0.00% |
| 2009 | 338.44M | 0.00% |
| 2008 | 338.44M | 0.00% |
| 2007 | 338.44M | 0.00% |
| 2006 | 338.44M | 0.00% |
| 2005 | 338.44M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 608.93% |
IN
|
